Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.6000 (6.06%) ($5.2800 - $5.7352) on Mon. Jun. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.77% (three month average) | RSI | 36 | Latest Price | $5.6000(6.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES declines -7.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UNG(6%) FIVG(5%) ICLN(5%) IFRA(5%) | Factors Impacting EYES price | EYES will decline at least -2.885% in a week (0% probabilities). BND(-8%) VCIT(-6%) LQD(-6%) XLP(-5%) VIXM(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.885% (StdDev 5.77%) | Hourly BBV | 0 () | Intraday Trend | 6.1% | | | |
|
1 - 5 Day Possible Target | $-20.7(-469.64%) | Resistance Level | $6.24 | 5 Day Moving Average | $5.41(3.51%) | 10 Day Moving Average | $5.62(-0.36%) | 20 Day Moving Average | $6.24(-10.26%) | To recent high | -38.6% | To recent low | 7.4% | Market Cap | $1.789b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |